AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35023846 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (with and without peer support)
Number of subjects: 81
Study 32444553 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal lifestyle intervention (INT) including bright light therapy (BLT), physical activity (PA), and sleep hygiene education
Number of subjects: 96
Study 32444553 — intervention group
Group type: COMPARATOR
Intervention: Education + attentional control (CON)
Number of subjects: 96
Study 36811372 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition + exercise intervention
Number of subjects: 17
Study 36811372 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 17
Study 32045087 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience-based co-design (EBCD) method adapted for a multi-site setting
Number of subjects: 0
Study 32045087 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-informed analysis
Number of subjects: 0
Study 32045087 — intervention group
Group type: COMPARATOR
Intervention: Cluster randomized controlled trial
Number of subjects: 0
Study 35422136 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral peritoneal flap (PIF)
Number of subjects: 530
Study 35422136 — intervention group
Group type: COMPARATOR
Intervention: No PIF (Control group)
Number of subjects: 530
Study 33534743 — intervention group
Group type: EXPERIMENTAL
Intervention: Household playspace (HPS) intervention
Number of subjects: 0
Study 32847918 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone Cardiac Rehabilitation, Assisted self-Management (SCRAM)
Number of subjects: 0
Study 32847918 — intervention group
Group type: COMPARATOR
Intervention: Usual care cardiac rehabilitation (UC)
Number of subjects: 0
Study 36146944 — intervention group
Group type: COMPARATOR
Intervention: Everolimus 10 mg once daily
Number of subjects: 95
Study 36146944 — intervention group
Group type: EXPERIMENTAL
Intervention: Sapanisertib 30 mg once weekly
Number of subjects: 95
Study 36146944 — intervention group
Group type: EXPERIMENTAL
Intervention: Sapanisertib 4 mg plus TAK-117 200 mg, both once daily for 3 days/week
Number of subjects: 95
Study 32945153 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 0
Study 32945153 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0
Study 32945153 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 10 mg
Number of subjects: 0
Study 32945153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36097401 — intervention group
Group type: EXPERIMENTAL
Intervention: Jacobson's Relaxation Technique (JRT)
Number of subjects: 312
Study 33112022 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva maneuver
Number of subjects: 84
Study 33112022 — intervention group
Group type: COMPARATOR
Intervention: Tenaculum
Number of subjects: 84
Study 34985381 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure <120mmHg
Number of subjects: 826
Study 34985381 — intervention group
Group type: EXPERIMENTAL
Intervention: Melancholic subtype
Number of subjects: 826
Study 34985381 — intervention group
Group type: EXPERIMENTAL
Intervention: Na+/K+ ratio
Number of subjects: 826
Study 34985381 — intervention group
Group type: EXPERIMENTAL
Intervention: K+ concentration
Number of subjects: 826
Study 34985381 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variation of MR-related genes
Number of subjects: 826
Study 34722452 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model using random forest algorithm for predicting sepsis
Number of subjects: 4449
Study 34722452 — intervention group
Group type: COMPARATOR
Intervention: Validation data set
Number of subjects: 4449
Study 32419688 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education and dietary counselling
Number of subjects: 257
Study 35813435 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandplay therapy (8 individual box court game tutoring sessions, once a week)
Number of subjects: 72
Study 35813435 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study 35813435 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandplay therapy
Number of subjects: 72
Study 34410046 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytological analysis of EUS-FNA samples
Number of subjects: 63
Study 36454123 — intervention group
Group type: EXPERIMENTAL
Intervention: EME+J
Number of subjects: 61
Study 36454123 — intervention group
Group type: EXPERIMENTAL
Intervention: DB+J
Number of subjects: 61
Study 36454123 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 61
Study 34400461 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) added to usual care
Number of subjects: 2510
Study 34400461 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to usual care
Number of subjects: 2510
Study 32305456 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength for U in Relationship Empowerment (SURE)
Number of subjects: 186
Study 32305456 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 186
Study 35296490 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Body-Mind-Spirit (I-BMS) intervention delivered to both parents and children
Number of subjects: 192
Study 35296490 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Body-Mind-Spirit (I-BMS) intervention delivered to parents only
Number of subjects: 192
Study 35296490 — intervention group
Group type: COMPARATOR
Intervention: Health education active control delivered to parents only
Number of subjects: 192
Study 32066548 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group (self-recorded eye movement videos during attacks)
Number of subjects: 60
Study 616743266 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular Attendance at MSG sessions during the 6-month postpartum period
Number of subjects: 88
Study 616743266 — intervention group
Group type: COMPARATOR
Intervention: Non-Regular Attendance at MSG sessions
Number of subjects: 88
Study 616743266 — intervention group
Group type: EXPERIMENTAL
Intervention: Older than 32 years
Number of subjects: 88
Study 616743266 — intervention group
Group type: EXPERIMENTAL
Intervention: Booking for antenatal care before 22 weeks gestational age
Number of subjects: 88
Study 616743266 — intervention group
Group type: EXPERIMENTAL
Intervention: Being on antiretroviral therapy at first antenatal care booking
Number of subjects: 88
Study 36458504 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected motivational music (WUMM)
Number of subjects: 10
Study 36458504 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-preferred music (WUNPM)
Number of subjects: 10
Study 36458504 — intervention group
Group type: COMPARATOR
Intervention: No music (WUWM)
Number of subjects: 10
Study 33592827 — intervention group
Group type: EXPERIMENTAL
Intervention: CONSULT-BP intervention (3-part program combining knowledge acquisition, bias awareness, and practice of bias mitigating skills in simulation-based communication encounters)
Number of subjects: 3
Study 33592827 — intervention group
Group type: EXPERIMENTAL
Intervention: CONSULT-BP intervention
Number of subjects: 3
Study 32801342 — intervention group
Group type: EXPERIMENTAL
Intervention: l-DOPA 100/25 mg
Number of subjects: 91
Study 32801342 — intervention group
Group type: EXPERIMENTAL
Intervention: l-DOPA 200/50 mg
Number of subjects: 91
Study 32801342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 35676006 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage and autotransfusion
Number of subjects: 1128
Study 35676006 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1128
Study 34112535 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (27 weeks, divided into 3 phases of 9 weeks each)
Number of subjects: 0
Study 34112535 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program
Number of subjects: 0
Study 32481262 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenke radiological grading scale
Number of subjects: 0
Study 32481262 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridwell radiological grading scale
Number of subjects: 0
Study 32481262 — intervention group
Group type: EXPERIMENTAL
Intervention: BSF (Brantigan, Steffe, Fraser) radiological grading scale
Number of subjects: 0
Study 32481262 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-HU radiological grading scale
Number of subjects: 0
Study 32481262 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful clinical outcome (SCO) defined as significant improvement in 2 of 3 of L-vas, R-vas, or ODI score at follow-up
Number of subjects: 0
Study 35922251 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemiplimab (350 mg intravenously every 3 weeks)
Number of subjects: 608
Study 35922251 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice)
Number of subjects: 608
Study 32542515 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuronavigated rTMS (10 Hz, 90% of resting motor threshold, 1,600 pulses over 20 min twice per day) for five days
Number of subjects: 74
Study 32542515 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 74
Study 33528092 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acidified aliphatic ester
Number of subjects: 32
Study 36564142 — intervention group
Group type: EXPERIMENTAL
Intervention: Degenerative fibroelastic chords
Number of subjects: 43
Study 36564142 — intervention group
Group type: COMPARATOR
Intervention: Normal chords
Number of subjects: 43
Study 33395336 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study 35882474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 35882474 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual treatment
Number of subjects: 31
Study 35882474 — intervention group
Group type: EXPERIMENTAL
Intervention: HFL treatment
Number of subjects: 31
Study 35882474 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual, HFL, and RF treatments
Number of subjects: 31
Study 32276098 — intervention group
Group type: EXPERIMENTAL
Intervention: PALO 0.25 mg IV infusion (30-minute infusion)
Number of subjects: 440
Study 32276098 — intervention group
Group type: COMPARATOR
Intervention: PALO 0.25 mg IV bolus (30-second bolus)
Number of subjects: 440
Study 35909478 — intervention group
Group type: EXPERIMENTAL
Intervention: PDCA nursing management
Number of subjects: 90
Study 35909478 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing management
Number of subjects: 90
Study 32681234 — intervention group
Group type: EXPERIMENTAL
Intervention: Kabat rehabilitation + facial taping
Number of subjects: 20
Study 32681234 — intervention group
Group type: COMPARATOR
Intervention: Kabat rehabilitation
Number of subjects: 20
Study 32420357 — intervention group
Group type: COMPARATOR
Intervention: HLA-Bw4
Number of subjects: 77
Study 32420357 — intervention group
Group type: COMPARATOR
Intervention: KIR3DL1-HLA-Bw4 combination
Number of subjects: 77
Study 32150657 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed Deprivation
Number of subjects: 8
Study 32150657 — intervention group
Group type: COMPARATOR
Intervention: Fed Conditions
Number of subjects: 8
Study 34552329 — intervention group
Group type: EXPERIMENTAL
Intervention: OMACOR (OM3EE) 2 g/day for 4 weeks, then 4 g/day for 8 weeks
Number of subjects: 0
Study 34552329 — intervention group
Group type: EXPERIMENTAL
Intervention: OMACOR (OM3EE)
Number of subjects: 0
Study 34552329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35704055 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based resistance exercise (HBRE) program for 12 weeks
Number of subjects: 72
Study 35704055 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 72
Study 34121351 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 71
Study 34121351 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 71
Study 34121351 — intervention group
Group type: COMPARATOR
Intervention: Locally developed stress reduction program (LSR)
Number of subjects: 71
Study 32564260 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and docetaxel
Number of subjects: 243
Study 32564260 — intervention group
Group type: COMPARATOR
Intervention: Placebo, trastuzumab, and docetaxel
Number of subjects: 243
Study 34164754 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical drill guide (SDG)
Number of subjects: 30
Study 34164754 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical drill guide with implant insertion guide (SDIG)
Number of subjects: 30
Study 34164754 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SDG and SDIG
Number of subjects: 30
Study 34070917 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Duolac ProAP4)
Number of subjects: 54
Study 34070917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 34455631 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of β‐NAG2 lotion for 8 weeks
Number of subjects: 33
Study 34455631 — intervention group
Group type: COMPARATOR
Intervention: Placebo lotion for 8 weeks
Number of subjects: 33
Study 32689617 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint mobilization
Number of subjects: 45
Study 32689617 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stretching
Number of subjects: 45
Study 32689617 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (joint mobilization and active stretching)
Number of subjects: 45
Study 36501060 — intervention group
Group type: EXPERIMENTAL
Intervention: p-synephrine (3 mg/kg)
Number of subjects: 16
Study 36501060 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 mg/kg cellulose)
Number of subjects: 16
Study 34051823 — intervention group
Group type: EXPERIMENTAL
Intervention: Infographic 1
Number of subjects: 100
Study 34051823 — intervention group
Group type: EXPERIMENTAL
Intervention: Infographic 2
Number of subjects: 100
Study 34051823 — intervention group
Group type: EXPERIMENTAL
Intervention: Infographic 3
Number of subjects: 100
Study 34051823 — intervention group
Group type: EXPERIMENTAL
Intervention: Infographic 4
Number of subjects: 100
Study 34051823 — intervention group
Group type: EXPERIMENTAL
Intervention: Infographic 5
Number of subjects: 100
Study 34051823 — intervention group
Group type: EXPERIMENTAL
Intervention: All infographics
Number of subjects: 100
Study 32141627 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use pre-diagnosis
Number of subjects: 4315
Study 32141627 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use 6 months post-diagnosis
Number of subjects: 4315
Study 32141627 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use during entire follow-up
Number of subjects: 4315
Study 32141627 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use (dose intensity analysis) 6 months post-diagnosis
Number of subjects: 4315
Study 36368598 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 76
Study 36368598 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in deep subcutaneous adipose tissue (dSAT)
Number of subjects: 76
Study 36368598 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in visceral adipose tissue volume
Number of subjects: 76
Study 36368598 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in dSAT and MRI hepatic proton density fat fraction (PDFF)
Number of subjects: 76
Study 32577886 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B complex supplements
Number of subjects: 331
Study 32577886 — intervention group
Group type: COMPARATOR
Intervention: Control group (blank control)
Number of subjects: 331
Study 35340059 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-syringe technique (DST)
Number of subjects: 30
Study 35340059 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-syringe technique (SST)
Number of subjects: 30
Study 33058054 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic gastrectomy
Number of subjects: 38
Study 33058054 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic gastrecty
Number of subjects: 38
Study 32051020 — intervention group
Group type: EXPERIMENTAL
Intervention: Ronopterin (VAS203)
Number of subjects: 0
Study 32051020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34075118 — intervention group
Group type: EXPERIMENTAL
Intervention: Grating group
Number of subjects: 30
Study 34075118 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 35405933 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g/kg body mass (BM)/d
Number of subjects: 8
Study 35405933 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 g/kg body mass (BM)/d
Number of subjects: 8
Study 35405933 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g/kg body mass (BM)/d
Number of subjects: 8
Study 33852360 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 pneumonia
Number of subjects: 150
Study 33852360 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza pneumonia
Number of subjects: 150
Study 33852360 — intervention group
Group type: EXPERIMENTAL
Intervention: Organizing pneumonia (OP)
Number of subjects: 150
Study 33852360 — intervention group
Group type: EXPERIMENTAL
Intervention: Favored diagnoses for COVID-19
Number of subjects: 150
Study 33852360 — intervention group
Group type: EXPERIMENTAL
Intervention: Favored diagnoses for influenza
Number of subjects: 150
Study 33852360 — intervention group
Group type: EXPERIMENTAL
Intervention: Favored diagnoses for OP
Number of subjects: 150
Study 35577011 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment adapted to primary care
Number of subjects: 369
Study 35577011 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 369
Study 32227756 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy (coronary angiography and revascularization if appropriate added to medical therapy)
Number of subjects: 777
Study 32227756 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy (medical therapy alone, angiography reserved for those in whom medical therapy had failed)
Number of subjects: 777
Study 32227756 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 777
Study 32227756 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 777
Study 35256192 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone
Number of subjects: 0
Study 35256192 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 0
Study 35256192 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study 33357682 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg/kg benzoic acid (BA1)
Number of subjects: 720
Study 33357682 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,000 mg/kg benzoic acid (BA2)
Number of subjects: 720
Study 33357682 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 720
Study 33417838 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlamydia and gonorrhoea testing via urine samples using the Xpert CT/NG test in four intervention clusters.
Number of subjects: 4440
Study 32020621 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist feedback on therapeutic alliance (TA)
Number of subjects: 155
Study 32020621 — intervention group
Group type: COMPARATOR
Intervention: No therapist feedback on therapeutic alliance (TA)
Number of subjects: 155
Study 35667730 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative lidocaine infusion at 1.33 mg/kg/hour
Number of subjects: 0
Study 35667730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32369853 — intervention group
Group type: EXPERIMENTAL
Intervention: CloFAL assay
Number of subjects: 87
Study 32369853 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer
Number of subjects: 87
Study 34020705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous vitamin C
Number of subjects: 1
Study 34020705 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1
Study 32989605 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted higher physical activity (PA) level
Number of subjects: 0
Study 32989605 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-Egger and weighted median methods
Number of subjects: 0
Study 32198617 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 90
Study 35660372 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (twice a week for 30 min for 8 weeks)
Number of subjects: 30
Study 35660372 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug treatment
Number of subjects: 30
Study 33826158 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-based exercise training (ET) within a cardiac rehabilitation (CR) program; specific dosage and duration not mentioned.
Number of subjects: 256
Study 33826158 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail); specific intervention details not mentioned.
Number of subjects: 256
Study 32078090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of 200 mL of still mineral water
Number of subjects: 8
Study 32078090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of 400 mL of still mineral water
Number of subjects: 8
Study 32078090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of 600 mL of still mineral water
Number of subjects: 8
Study 32078090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of 800 mL of still mineral water
Number of subjects: 8
Study 32078090 — intervention group
Group type: EXPERIMENTAL
Intervention: All volumes of water greater than 200 mL
Number of subjects: 8
Study 32078090 — intervention group
Group type: EXPERIMENTAL
Intervention: Time effects on heart rate variability parameters
Number of subjects: 8
Study 34039154 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality game playing (1 hour per day, 5 days a week for 4 weeks)
Number of subjects: 50
Study 34039154 — intervention group
Group type: COMPARATOR
Intervention: Patching (occlusion of non-amblyopic eye for 2, 4, and 6 hours based on severity)
Number of subjects: 50
Study 36079790 — intervention group
Group type: EXPERIMENTAL
Intervention: EAA+ (9 g EAAs, 3 g leucine)
Number of subjects: 12